| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_850a17186ff51f03c607cf42a534a635 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2770-24322
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-24143
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-92
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N7-04 |
| filingDate |
1987-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_81947578199b1ccedc5938fe6fa3c278
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c4dddeae25312a424aa55d50f39dd4cd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1225e1b8197b0bf84428cc78707caf9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d8f0696b0c3d4bf63ee09bbbda7b4dd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1cacb3bd6c29d48122ff00487ef6802b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13cc9be30c645b913e65407306680b75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24e0ed1cbd99030b6c2b1028c504e65b |
| publicationDate |
1989-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-H01117780-A |
| titleOfInvention |
Recombinant vaccinia virus |
| abstract |
PURPOSE:To provide a recombinant vaccinia virus giving a Japanese encephalitis vaccine useful for the prevention of Japanese encephalitis, by using cDNA of a gene coding a structural protein of Japanese encephalitis virus as an active component. CONSTITUTION:A plasmid containing cDNA of a gene coding a structural protein of Japanese encephalitis virus is prepared. The plasmid is transfected to a wild-type vaccinia virus-infected cell by conventional method such as calcium phosphate method to cause homologous recombination in the cell and obtain a recombinant vaccinia virus containing cDNA of a gene coding a structural protein of Japanese encephalitis virus. The obtained recombinant vaccinia virus can be used as a vaccine, i.e. prophylactic inoculation agent for Japanese encephalitis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1604685-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H02303482-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9911762-A1 |
| priorityDate |
1987-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |